Literature DB >> 6471186

Vesicourethral dysfunction following pelvic visceral ablative surgery.

S V Yalla, G L Andriole.   

Abstract

Management of vesicourethral dysfunction after a major extirpative pelvic visceral operation could be complex and difficult owing to the variety of partial and complete functional and anatomical derangements produced by the primary operation. We report our experience with 22 patients who suffered various types of vesicourethral dysfunctions after extirpative pelvic visceral surgery, 5 of whom had preoperative studies. The surgical procedures were abdominoperineal resection in 9 patients, proctocolectomy in 3, anterior resection of the rectum in 2 and radical hysterectomy in 8. All 22 patients underwent urodynamic evaluations. The abnormalities noted on the preoperative urodynamic evaluations in patients about to undergo extirpative pelvic visceral surgery suggest the need for routine preoperative assessment of the lower urinary tract for an accurate understanding of the postoperative changes.

Entities:  

Mesh:

Year:  1984        PMID: 6471186     DOI: 10.1016/s0022-5347(17)49711-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemia.

Authors:  H Masuda; T Tsujii; T Okuno; K Kihara; M Goto; H Azuma
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  The anatomical basis and prevention of neurogenic voiding dysfunction following radical hysterectomy.

Authors:  X K Tong; R J Huo
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

3.  Urodynamic patterns after traumatic spinal cord injury.

Authors:  Mahima Agrawal; Mrinal Joshi
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

4.  Autonomic influences on colorectal motility and pelvic surgery.

Authors:  J S Varma
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.